Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction
1998 · Biochemical Journal · 58 citations
https://doi.org/10.1042/bj3310113
G
Guo Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
4.1K
Citations
35
h-index
70
i10-index
Guo Huang is an academic researcher from Wenzhou Medical University. The author has contributed to research in topics: Pancreatic function and diabetes & Diabetes and associated disorders & Diabetes Management and Research. The author has an h-index of 35, co-authored 97 publications.
ORCID: 0000-0002-4452-9243Papers by this author
worksReduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2
1997 · Oncogene · 43 citations
https://doi.org/10.1038/sj.onc.1201595
C3aR and C5aR1 act as key regulators of human and mouse β-cell function
2017 · Cellular and Molecular Life Sciences · 39 citations
https://doi.org/10.1007/s00018-017-2655-1
Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets
2018 · Cellular and Molecular Life Sciences · 35 citations
https://doi.org/10.1007/s00018-018-2778-z
Epigenetic modification and BRAF gene mutation in thyroid carcinoma
2021 · Cancer Cell International · 29 citations
https://doi.org/10.1186/s12935-021-02405-w
A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
2022 · Hepatology International · 29 citations
https://doi.org/10.1007/s12072-022-10354-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat